Determination of Tear and Serum Inflammatory Cytokines in Patients with Rosacea Using Multiplex Bead Technology

References

• Culp B, Scheinfeld N. Rosacea: a review. Pharm Therapeut. 2009;34:38–45
   Google Scholar
• Stone DU, Chodosh J. Ocular rosacea: an update on pathogenesis and therapy. Curr Opin Ophthalmol. 2004;15:499–502
   PubMedGoogle Scholar
• Browning DJ, Proia AD. Ocular rosacea. Surv Ophthalmol. 1986;31:145–158
   PubMed Web of Science ®Google Scholar
• Ghanem VC, Mehra N, Wong S, et al. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea. 2003;22:230–233
   PubMed Web of Science ®Google Scholar
• Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51:327–341
   PubMed Web of Science ®Google Scholar
• Aroni K, Tsagroni E, Lazaris AC, et al. Rosacea: a clinicopathological approach. Dermatology. 2004;209:177–182
   PubMed Web of Science ®Google Scholar
• Helm KF, Menz J, Gibson LE, et al. A clinical and histopathologic study of granulomatous rosacea. J Am Acad Dermatol. 1991;25:1038–1043
   PubMed Web of Science ®Google Scholar
• Barton K, Monroy DC, Nava A, et al. Inflammatory cytokines in tears of patients with ocular rosacea. Ophthalmology. 1997;104:1868–1874
   PubMed Web of Science ®Google Scholar
• Afonso AA, Sobrin L, Monroy DC, et al. Tear fluid gelatinase B activity correlates with IL-1α concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci. 1999;40:2506–2512
   PubMed Web of Science ®Google Scholar
• Määttä M, Kari O, Tervahartiala T, et al. Tear fluid levels of MMP-8 are elevated in ocular rosacea-treatment effect of oral doxycycline. Graefe's Arch Clin Exp Ophthalmol. 2006;244:957–962
   PubMed Web of Science ®Google Scholar
• Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods. 2000;243:243–255
   PubMed Web of Science ®Google Scholar
• Dupont NC, Wang K, Wadhwa PD, et al. Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol. 2005;66:175–191
   PubMed Web of Science ®Google Scholar
• Ray CA, Bowsher RR, Smith WC, et al. Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum. J Pharm Biomed Anal. 2005;36:1037–1044
   PubMed Web of Science ®Google Scholar
• Berg M, Linden S. An epidemiological study of rosacea. Acta Derm Venereol. 1989;69:419–423
   PubMed Web of Science ®Google Scholar
• Fredricks DN. Microbial ecology of human skin in health and disease. J Investig Dermatol Symp Proc. 2001;6:167–169
   PubMed Web of Science ®Google Scholar
• Milikan LE. Rosacea as an inflammatory disorder: a unifying theory? Cutis. 2004;73(suppl 1):5–8
   PubMedGoogle Scholar
• Solomon A, Dursun D, Liu Z, et al. Pro- and anti-inflammatury forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283–2292
   PubMed Web of Science ®Google Scholar
• Uchio E, Ono SY, Ikezawa Z, et al. Tear levels of interferon-gamma, interleukin (IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin Exp Allergy. 2000;30:103–109
   PubMed Web of Science ®Google Scholar
• Lam H, Bleiden L, De Paiva CS, et al. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009;147:198–205
   PubMed Web of Science ®Google Scholar
• Erdogan-Poyraz C, Mocan MC, Bozkurt B, et al. Elevated tear interleukin-6 and interleukin-8 levels in patients with conjunctivochalasis. Cornea. 2009;28:189–193
   PubMed Web of Science ®Google Scholar
• Dinarello CA. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol. 2002;20:1–13
   PubMed Web of Science ®Google Scholar
• Jiang Y, Genant HK, Watt I, et al. A multicenter double-blind, dose ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum. 2000;43:1001–1009
   PubMed Web of Science ®Google Scholar
• Salvi GE, Lang NP. Host response modulation in the management of periodontal diseases. J Clin Periodontol. 2005;32(Suppl 6):108–129
   PubMedGoogle Scholar
• Rosenbaum JT, Planck ST, Huang XN, et al. Detection of mRNA for the cytokines, interleukin-1 alpha and interleukin-8, in corneas from patients with pseudophakic bullous keratopathy. Invest Ophthalmol Vis Sci. 1995;36:2151–2155
   PubMed Web of Science ®Google Scholar
• Staats HF, Lausch RN. Cytokine expression in vivo during murine herpetic stromal keratitis. J Immunol. 1993;151:277–283
   PubMed Web of Science ®Google Scholar
• Di Girolamo N, Kumar RK, Coroneo MT, et al. UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2002;43:3430–3437
   PubMed Web of Science ®Google Scholar
• Kishimoto K. The biology of interleukin 6. Blood. 1989;74:1–10
   PubMed Web of Science ®Google Scholar
• Yoon KC, Jeong IY, Park YG, et al. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea. 2007;26:431–437
   PubMed Web of Science ®Google Scholar
• Acera A, Rocha G, Vecino E, et al. Inflammatory markers in the tears of patients with ocular surface diseases. Ophthalmic Res. 2008;40:315–321
   PubMed Web of Science ®Google Scholar
• Schroder JM, Noso N, Sticherling M, et al. Role of eosinophil-chemotactic C-C chemokines in cutaneous inflammation. J Leukoc Biol. 1996;59:1–5
   PubMedGoogle Scholar
• Keeley EC, Mehrad B, Strieter RM. Chemokines as mediators of neovascularization. Arterioscler Thromb Vasc Biol. 2008;28:1928–1936
   PubMed Web of Science ®Google Scholar
• Salcedo R, Ponce ML, Young HA, et al. Human endothelial cells express CCR2 in response to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood. 2000;96:34–40
   PubMed Web of Science ®Google Scholar
• Hong KH, Ryu J, Han KH. Monocyte chemoattractant protein-1 induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 2005;105:1405–1407
   PubMed Web of Science ®Google Scholar
• Spandau UH, Toksoy A, Verhaart S, et al. High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo. Arch Ophthalmol. 2003;121:825–831
   PubMed Web of Science ®Google Scholar
• Malvitte L, Montange T, Vejux A, et al. Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs. Br J Ophthalmol. 2007;91:29–32
   PubMed Web of Science ®Google Scholar
• Chong RS, Jiang YZ, Boey PY, et al. Tear cytokine profile in medicated glaucoma patients: Effect of monocyte chemoattractant protein 1 on ealy posttrabeculectomy outcome. Ophthalmology. 2010;117:2353–2358
   PubMed Web of Science ®Google Scholar
• Maurer M, von Stebut E. Macrophage inflammatory protein-1. Int J Biochem Cell Biol. 2004;36:1882–1886
   PubMed Web of Science ®Google Scholar
• Hatano Y, Katagiri K, Takayasu S. Increased levels in vivo of mRNAs for IL-8 and macrophage inflammatory protein-1a (MIP-1a), but not of RANTES mRNA in peripheral blood mononuclear cells of patients with atopic dermatitis (AD). Clin Exp Immunol. 1999;117:237–243
   PubMedGoogle Scholar
• Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood. 2000;95:3032–3043
   PubMed Web of Science ®Google Scholar
• Couper KN, Blount DG, Riley EM. IL-10: The master regulator of immunity to infection. J Immunol. 2008;180:5771–5777
   PubMed Web of Science ®Google Scholar
• Weiss E, Mamelak AJ, La Morgia S et al,. The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases. J Am Acad Dermatol. 2004;50:657–675
   PubMedGoogle Scholar
• Asadullah K, Sterry W, Stephanek K, et al. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest. 1998;101:783–794
   PubMed Web of Science ®Google Scholar
• Aleksza M, Lukacs A, Antal-Szalmas P, et al. Increased frequency of intracellular interleukin (IL)-13 and IL-10, but not IL-4, expressing CD4- and CD8-peripheral T cells of patients with atopic dermatitis. Br J Dermatol. 2002;147:1135–1141
   PubMedGoogle Scholar
• Detmar M, Brown LF, Claffey KP, et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med. 1994;180:1141–1146
   PubMed Web of Science ®Google Scholar
• Brown LF, Harrist TJ, Yeo KT, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol. 1995;104:744–749
   PubMed Web of Science ®Google Scholar
• Xia YP, Li B, Hylton D, Yancopoulos GD, et al. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood. 2003;102:161–168
   PubMed Web of Science ®Google Scholar
• Ozturk BT, Bozkurt B, Kerimoglu H, et al. Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness. Mol Vision. 2009;15:1906–1914
   PubMed Web of Science ®Google Scholar
• Smith JR, Lanier VB, Braziel RM, et al. Expression of vascular endothelial growth factor and its receptors in rosacea. Br J Ophthalmol. 2007;91:226–229
   PubMed Web of Science ®Google Scholar